Ameditech Inc recalls DrugCheck Pipette 10 Drug Test, Item No. 41025 DC These Drugs of Abuse Tests are one-step immunoassays for the qualitat

Recalled November 25, 2015 · FDA recall Z-0305-2016 · Ameditech

Hazard

Ameditech is recalling drug abuse tests because they have shown reduced reactivity. · FDA Class II

Units

70 units

Sold at

Worldwide Distribution - US (nationwide) and Internationally to Australia.

Description

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Product

DrugCheck Pipette 10 Drug Test, Item No. 41025 DC These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Manufacturer(s)

Ameditech Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →